References
- Cho YY, Song JS, Park HD, et al. (2017). First report of familial dysalbuminemic hyperthyroxinemia with an ALB variant. Ann Lab Med 37:63–5
- Cui C, Shu C, Cao D, et al. (2016). UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. Oncol Lett 12:4231–7
- Fang ZZ, He RR, Cao YF, et al. (2013). A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders. J Lipid Res 54:3334–44
- Findlay KA, Kaptein E, Visser TJ, Burchell B. (2000). Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab 85:2879–83
- Gao X, Qu H, Ai CZ, et al. (2015). Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms. Xenobiotica 45:197–206
- Gokmen FY, Ahbab S, Ataoglu HE, et al. (2016). FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics (Sao Paulo) 71:221–5
- Guo Y, Hu B, Xie Y, et al. (2016). Regulation of drug-metabolizing enzymes by local and systemic liver injuries. Expert Opin Drug Metab Toxicol 12:245–51
- Izumi Y, Hidaka Y, Tada H. (2002). Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis. Clin Endocrinol (Oxf) 57:51–8
- Kallionpaa RA, Jarvinen E, Finel M. (2015). Glucuronidation of estrone and 16α-hydroxyestrone by human UGT enzymes: the key roles of UGT1A10 and UGT2B7. J Steroid Biochem Mol Biol 154:104–11
- Kozdag G, Ural D, Vural A, et al. (2005). Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail 7:113–18
- Lee MN, Lee SY, Hur KY, Park HD. (2017). Thyroxine (T4) autoantibody interference of free T4 concentration measurement in a patient with Hashimoto's thyroiditis. Ann Lab Med 37:169–71
- Liu X, Cao YF, Dong PP, et al. (2017). The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A. Xenobiotica 47:376–81
- Naritomi Y, Nakamori F, Furukawa T, Tabata K. (2015). Prediction of hepatic and intestinal glucuronidation using in vitro-in vivo extrapolation. Drug Metab Pharmacokinet 30:21–9
- Oda S, Fukami T, Yokoi T, Nakajima M. (2015). A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metab Pharmacokinet 30:30–51
- Shu-Yao Z, Hong J, Chao-Xian L, et al. (2013). In vitro evidence of possible influence of scutellarein towards bile acids' metabolism. Afr Health Sci 13:556–9
- Suda S, Muraga K, Kanamaru T, et al. (2016). Low free triiodothyronine predicts poor functional outcome after acute ischemic stroke. J Neurol Sci 368:89–93
- Tomita Y, Ishiguro H, Shinagawa T, et al. (2003). Persistence of mild hyperthyrotropinemia after discontinuation of three-year course of low-dose L-thyroxine therapy in infants with borderline hypothyroidism. Endocr J 50:379–84
- Tong Z, Li H, Goljer I, et al. (2007). In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 35:2203–10
- Trottier J, El Husseini D, Perreault M, et al. (2010). The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liver. J Biol Chem 285:1113–21
- Tsoutsikos P, Miners JO, Stapleton A, et al. (2004). Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem Pharmacol 67:191–9
- Uchiyama A, Kushima R, Watanabe T, Kusuda S. (2015). Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial. J Pediatr Endocrinol Metab 28:177–82
- Uno Y, Uehara S, Yamazaki H. (2016). Utility of non-human primates in drug development: comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes. Biochem Pharmacol 121:1–7
- Yoshimura NJ, Momotani N, Fukada S, et al. (2005). Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. Endocr J 52:537–42
- Yuan L, Qian S, Xiao Y, et al. (2015). Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity. Biochem Pharmacol 95:58–70